Switch to:
More From Other Websites
Teva, Allergan win U.S. antitrust approval for generics deal Jul 27 2016
Teva, Allergan win U.S. antitrust approval for generics deal Jul 27 2016
Teva, Allergan win U.S. antitrust approval for generics deal Jul 27 2016
Teva, Allergan win U.S. antitrust approval for generics deal Jul 27 2016
Teva expect to close $40.5B Allergan generic deal next week Jul 27 2016
Teva expect to close $40.5B Allergan generic deal next week Jul 27 2016
Teva to Report Second Quarter 2016 Financial Results on August 4, 2016 Jul 27 2016
[$$] Teva, Allergan Get FTC Approval for Generics Purchase Jul 27 2016
FTC approves Teva's $40.5B deal for Allergan's generics business Jul 27 2016
Teva Wins U.S. Nod for Actavis After Divestiture of 79 Drugs Jul 27 2016
Teva purchase of Allergan generics business approved with conditions Jul 27 2016
2:37 pm Teva Pharma confirms FTC clearance for Actavis (AGN unit) generics acquisition; transaction... Jul 27 2016
Teva Receives Clearance from the U.S. Federal Trade Commission for Actavis Generics Acquisition Jul 27 2016
Teva Wins U.S. Approval to Buy Actavis After Selling Generics Jul 27 2016
Short Sellers Get Selective on Major Pharma Jul 27 2016
Alder Biopharma Migraine Drug Holds Up After 6 Months Jul 25 2016
Investor Demand for U.S. Corporate Bond Remains Insatiable Jul 25 2016
Specialty Pharma: Earnings Better Be Good…or Else Jul 25 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK